EPT Disclosure
August 06 2007 - 7:02AM
UK Regulatory
ABN AMRO BANK N.V.
FORM 38.5(a)
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS
WITH RECOGNISED INTERMEDIARY STATUS
DEALING IN A CLIENT-SERVING CAPACITY
(Rule 38.5(a) of the Takeover Code)
1. KEY INFORMATION
Name of exempt principal trader ABN AMRO BANK N.V. London Branch
---------------------------------------------------------------------------------------------------------
Company dealt in Computer Science Corporation
---------------------------------------------------------------------------------------------------------
Class of relevant security to which the 1.00 USD
dealings being disclosed relate (Note 1)
---------------------------------------------------------------------------------------------------------
Date of dealing 2nd August 2007
---------------------------------------------------------------------------------------------------------
2. DEALINGS (Note 2)
(a) Purchases and sales
Total number of securities Highest price paid (Note 3) Lowest price paid (Note 3)
purchased
---------------------------------------------------------------------------------------------------------
18,768 55.9987 USD 55.9987 USD
---------------------------------------------------------------------------------------------------------
Total number of securities sold Highest price received (Note 3) Lowest price received (Note 3)
---------------------------------------------------------------------------------------------------------
18,768 55.9979 USD 55.9979 USD
---------------------------------------------------------------------------------------------------------
(b) Derivatives transactions (other than options)
Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3)
e.g. CFD
--------------------------------------------------------------------------------------------------------
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, e.g. Expiry Option money
e.g. call option selling, securities to price American, date paid/received
purchasing, which the option European per unit (Note
varying etc. relates (Note 5) etc. 3)
-------------------------------------------------------------------------------------------------------
(ii) Exercising
Product name, e.g. call option Number of securities Exercise price per unit (Note 3)
---------------------------------------------------------------------------------------------------------
3. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other
person relating to the voting rights of any relevant securities under any option referred to on this
form or relating to the voting rights or future acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
---------------------------------------------------------------------------------------------------------
Date of disclosure 6th August 2007
---------------------------------------------------------------------------------------------------------
Contact name Antonio Gagliostro
---------------------------------------------------------------------------------------------------------
Telephone number 020 7678 5898
---------------------------------------------------------------------------------------------------------
Name of offeree/offeror with which connected IBA Health Ltd
---------------------------------------------------------------------------------------------------------
Nature of connection (Note 6) Financial Advisor
---------------------------------------------------------------------------------------------------------
Notes
The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
Cscape (LSE:CSC)
Historical Stock Chart
From Jul 2024 to Aug 2024
Cscape (LSE:CSC)
Historical Stock Chart
From Aug 2023 to Aug 2024